Allakos Inc. announced the appointment of Neil Graham, M.D. to the Allakos board of directors. Dr. Graham was the Chief Medical Officer of Tiziana Life Sciences Limited and currently serves on the board of directors of Aslan Pharmaceuticals Limited, Pharmaxis Limited and Zura Bio Limited. Among other experiences, Dr. Graham was the Vice President of Strategic Program Direction, Immunology and Inflammation at Regeneron Pharmaceuticals Inc. and he received his M.D. from the University of Adelaide.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | -0.69% | +20.00% | -47.25% |
May. 09 | Allakos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 15 | North American Morning Briefing : Inflation Worries Continue to Weigh on Mood | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.25% | 128M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- ALLK Stock
- News Allakos Inc.
- Allakos Inc. Appoints Neil Graham to its Board of Directors